CSF3 and acute myeloid leukemia: Recent clinical studies have demonstrated that HLA-mismatched granulocyte colony-stimulating factor–mobilized donor peripheral blood stem cell (G-PBSC) infusion after regular chemotherapy improves the outcome in elderly patients with acute myeloid leukemia (AML) [71–74].